Evidence map›Paper›PMID 38902391›Full record

ArticleScientific reports2024

A prominent role of LncRNA H19 in H. pylori CagA induced DNA damage response and cell malignancy.

Xiaofeng He, Tingting Huang, Qinrong Wang, Liya Bao, Zhengrong Wang, Hui Song, Yanhong Li, Jianjiang Zhou, Yan Zhao, Yuan Xie

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Advances inOncology letters · 2026
    Review
  2. Review
  3. Review
  4. World journal of gastrointestinal oncology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaofeng He *Key Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China.
Tingting Huang *Key Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China.
Qinrong Wang *Key Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China.
Liya BaoHepatitis Laboratory, Department of Infectious Diseases, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, Guizhou, People's Republic of China.
Zhengrong WangSchool of Clinical Laboratory Science, Guizhou Medical University, Guiyang, 550004, Guizhou, People's Republic of China.
Hui SongKey Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China.
Yanhong LiKey Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China.
Jianjiang ZhouKey Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China. jianjiangzhou@sina.cn.
Yan ZhaoKey Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China. 501155185@qq.com.
Yuan XieKey Laboratory of Endemic and Ethnic Minority Diseases, Ministry of Education and Key Laboratory of Molecular Biology, Guizhou Medical University, 4 Beijing Road, Guiyang, 550004, Guizhou, People's Republic of China. 37408126@qq.com.

Funding

Guizhou Provincial Science and Technology Projects [2020]1Y333Guizhou Provincial Science and Technology Projects QianKeHe JC [2020]1Z010Guizhou Provincial Science and Technology Projects ZK[2022]041National Natural Science Foundation of China 31960028National Natural Science Foundation of China 32160166National Natural Science Foundation of China 82260405The project of Guizhou Medical University 21NSFC03
6 · The paper itself

Abstract

Helicobacter pylori (H. pylori), together with its CagA, has been implicated in causing DNA damage, cell cycle arrest, apoptosis, and the development of gastric cancer. Although lncRNA H19 is abundantly expressed in gastric cancer and functions as a pro-oncogene, it remains unclear whether lncRNA H19 contributes to the oncogenic process of H. pylori CagA. This study investigates the role of H19 in the DNA damage response and malignancy induced by H. pylori. It was observed that cells infected with CagA

Indexed as

Antigens, BacterialBacterial ProteinsCell MovementDNA DamageHelicobacter pyloriRNA, Long NoncodingStomach NeoplasmsCell Line, TumorHelicobacter InfectionsHistonesHumansRad51 RecombinaseTumor Suppressor Protein p53Antigens, BacterialBacterial ProteinscagA protein, Helicobacter pyloriH19 long non-coding RNAH2AX protein, humanHistonesRAD51 protein, humanRad51 RecombinaseRNA, Long NoncodingTumor Suppressor Protein p53DNA damage responseGastric cancerHelicobacter pylori (H. pylori)InvasionLncRNA H19Migration

Identifiers

PMID38902391
PMCPMC11190245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.